Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Edwards Lifesciences
EW
$51.7B
| $286M | 0.2% |
3,826,678
-10,970,786
| -74% | -$846M |
|
127
Prologis
PLD
$133B
| $282M | 0.2% |
2,496,340
-1,343,078
| -35% | -$149M |
|
128
CarMax
KMX
$8.26B
| $277M | 0.2% |
4,542,508
-4,458,794
| -50% | -$286M |
|
129
Centene
CNC
$32.5B
| $266M | 0.19% |
3,245,835
-3,740,689
| -54% | -$306M |
|
130
Adobe
ADBE
$105B
| $266M | 0.19% |
789,029
-1,686,677
| -68% | -$539M |
|
131
Johnson & Johnson
JNJ
$625B
| $265M | 0.19% |
1,502,488
-1,563,106
| -51% | -$270M |
|
132
Zoetis
ZTS
$30B
| $262M | 0.19% |
1,787,341
-1,913,633
| -52% | -$283M |
|
133
Burlington
BURL
$23.2B
| $258M | 0.18% |
1,272,448
-1,340,822
| -51% | -$214M |
|
134
Cboe Global Markets
CBOE
$29.9B
| $257M | 0.18% |
2,045,125
-3,636,279
| -64% | -$449M |
|
135
Dynatrace
DT
$14.2B
| $256M | 0.18% |
6,691,228
-7,467,274
| -53% | -$271M |
|
136
iShares Core US Aggregate Bond ETF
AGG
$138B
| $255M | 0.18% |
2,634,279
-2,197,895
| -45% | -$213M |
|
137
Aon
AON
$76B
| $248M | 0.18% |
826,004
-1,874,800
| -69% | -$548M |
|
138
Teck Resources
TECK
$32.6B
| $246M | 0.18% |
6,509,068
-7,164,674
| -52% | -$248M |
|
139
Cisco
CSCO
$479B
| $241M | 0.17% |
5,050,167
-3,027,925
| -37% | -$138M |
|
140
VICI Properties
VICI
$29.4B
| $239M | 0.17% |
7,366,763
-9,063,089
| -55% | -$291M |
|
|
141
Alphabet (Google) Class A
GOOGL
$4.33T
| $236M | 0.17% |
2,675,260
-4,361,982
| -62% | -$415M |
|
142
Avantor
AVTR
$9.19B
| $230M | 0.16% |
10,906,319
-9,449,643
| -46% | -$196M |
|
143
Elevance Health
ELV
$85.5B
| $230M | 0.16% |
447,744
-558,086
| -55% | -$283M |
|
144
Chevron
CVX
$366B
| $229M | 0.16% |
1,277,348
-230,036
| -15% | -$40.1M |
|
145
Coca-Cola
KO
$375B
| $229M | 0.16% |
3,600,303
-4,577,813
| -56% | -$276M |
|
146
Dentsply Sirona
XRAY
$2.43B
| $229M | 0.16% |
7,178,328
-7,791,478
| -52% | -$235M |
|
147
Trane Technologies
TT
$106B
| $228M | 0.16% |
1,356,203
-1,247,921
| -48% | -$206M |
|
148
Apollo Global Management
APO
$73.4B
| $227M | 0.16% |
3,551,711
-3,584,057
| -50% | -$213M |
|
149
Intuitive Surgical
ISRG
$134B
| $224M | 0.16% |
844,066
-1,466,942
| -63% | -$358M |
|
150
Ryanair
RYAAY
$31.3B
| $220M | 0.16% |
7,371,098
-7,340,077
| -50% | -$208M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 209 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 209 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.